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Abstract
Background: FGF21,as a member of the fibroblast growth factor superfamily, is an important endogenous regulator to
systemic glucose and lipid metabolism. Elevated serum FGF21 levels have been reported in subjects with coronary
heart disease and carotid artery plaques. The formation and apoptosis of foam cell, induced by ox-LDL and oxysterols,
are key steps in the development of atherosclerosis.
Methods: In this study, THP1 derived macrophages were induced into foam cells by ox-LDL or sterols. The formation
and apoptosis of foam cells treated with or without FGF21 were analyzed.
Results: We demonstrated that the accumulation of cholesterol was decreased after FGF21 treatment in THP1
macrophage derived foam cells. Consistently, the apoptosis of macrophage was alleviated dramatically with FGF21
treatment. ERK1/2 knockdown didn’t abrogate the effect of FGF21 on THP1 macrophage derived foam cells. However,
FGF21 suppressed the induced expression of CHOP and DR5 in THP1 macrophage derived foam cells.
Conclusion: FGF21 protects against the formation and apoptosis of THP1 macrophages derived foam cells through
suppressing the expression of CHOP.
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Background
Fibroblast growth factor (FGF) superfamily,, has an import-
ant functions in metabolic processes. Among members of
the FGF superfamily, FGF21 plays a very important regula-
tory role in glucose and lipid homeostasis [1–3].
The role of FGF21 in glucose and lipid metabolism
has been well studied [4, 5]. Human recombinant FGF21
has been demonstrated to stimulate glucose incorporation
in mouse and human adipocytes, and to lower blood glu-
cose and triglyceride levels in diabetic and obese mice as
well as diabetic monkeys [6]. By contrast, FGF21 deficient
mice showed mild weight gain, slightly impaired glucose
homeostasis, and also developed hepatosteatosis and obvi-
ous impairments in ketogenesis and glucose control when
raised on a ketogenic diet [7]. These findings suggest that
FGF21 is an important metabolic hormone in maintaining
glucose and lipid homeostasis. Recently, it is reported that
serum FGF21 levels are increased in coronary heart
disease (CHD) and FGF21 is also found in carotid artery
plaques [5, 8, 9]. In myocardial infarction, FGF21could
attenuate pathological myocardial remodeling through the
adiponectin-dependent mechanism [10]. What’s more,
FGF21 have also been found to attenuate hyperlipidemia
and diabetes induced early-stage apoptosis [11]. Based on
these results, FGF21 has been proposed to be associated
with arteriosclerosis. However, the role of FGF21 in
arteriosclerosis remains unclear.
In normal macrophages, low density lipoprotein (LDL)
cholesterol particles are loaded from late endosomes to the
ER. In the ER, cholesterol is esterified and accumulated to
form inert lipid droplets [12, 13]. In atherosclerotic macro-
phages, ER-mediated cholesterol reesterification is mark-
edly impaired resulting in excessive intracellular deposits of
nonesterified cholesterol and the formaition of foam cells
[13], where intraluminal ER oxidoreductases oxidize chol-
esterol to 7-ketocholesterol (7-KC) and other oxysterols.
* Correspondence: jyzhangzzu@126.com
1Department of Cardiovascular internal medicine, The first Affiliated Hospital
of Zhengzhou University, Zhengzhou, P. R. China
Full list of author information is available at the end of the article
© 2015 Li et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Li et al. BMC Cardiovascular Disorders  (2015) 15:80 
DOI 10.1186/s12872-015-0077-2
Oxysterols are highly cytotoxic and may induce cell death
through ROS-mediated oxidative damage [14]. Prolonged
ER stress contributes to apoptosis of lesional macrophages,
which is associated with robust expression of C/EBP
homologous protein (CHOP) in human lesions [15] and
atherosclerotic plaques of apolipoprotein (apo) E-deficient
mice [16]. Inactivating CHOP in apoE-deficient mice slows
down macrophage apoptosis and plaque necrosis [17–19].
CHOP contributes to ER stress-induced macrophage death
by inducing Fas activation, depletion of ER-associated cal-
cium stores, and release of apoptogens from mitochondria
[19]. Moreover, CHOP is found to induce cell apoptosis
through activating death receptor 5 (DR5) in human carcin-
oma cells [20].
Methods
Isolation and oxidation of Low density lipoprotein
The native low-density lipoprotein (LDL) was obtained
from Sigma. LDL was oxidized with CuSO4 at 37 °C for
18 h and transferred into ethylene diamine tetraacetic acid
(EDTA; 200 mM) in phosphate-buffered saline (PBS) for
24 h at 4 °C to remove Cu2+. Subsequently, the product
was dialyzed in PBS for 24 h at 4 °C to remove EDTA.
LDL oxidation was confirmed by thiobarbituric acid reac-
tion substances with malondialdehyde as the standard.
The content of ox-LDL was 1.12 compared with
0.30 nmol/100 mg protein in the native LDL preparation
(p < 0.01). The ox-LDL was then sterilized by filtration
and stored at 4 °C as previously described [21].
Cell Culture
The human THP-1 cells were obtained from the Type
Culture Collection of the Chinese Academy of Sci-
ences (Shanghai, China). THP-1 cells were cultured in
Roswell Park Memorial Institute medium 1640 (RPMI
1640, Hyclone) containing 10 % fetal bovine serum
and 2 mM L-glutamine. The cells were differentiated
into macrophages by adding 100 ng/mL phorbol 12-
myristate-13-acetate for 24 h, and the medium was
then replaced with that containing ox-LDL (50 mg/mL)
and human FGF21 (Peprotech, 20 nmol/L) for 24 h to
obtain fully differentiated foam cells before use in ex-
periments. And human FGF21 (Peprotech, 20 nmol/L)
was added to cotreat the THP1 macrophage derived
foam cell.
SiRNA transfection
THP-1 cells were transfected with specific siRNA oligo-
mers directed against Erk (80 nM) using Lipofectaminqe
2000 transfection reagent (Invitrogen, Carlsbad, CA)
according to the manufacturer’s instructions. Negative
control siRNA oligomers were used as a negative con-
trol. After transfection for 48 h, the cells were exposed
to ox-LDL (50 mg/L) for 24 h. The silencing of target
genes was validated by western blotting.
Western blotting
Total proteins and nuclear proteins from cells were
extracted using RIPA lysis buffer and nuclear extraction
kits, respectively, following the manufacturer’s instructions.
Equal amounts of protein were separated by SDS-PAGE
and probed with various primary antibodies as indicated.
Immunoblots were visualized using ECL reagent, and the
integrated optical density (IOD) of immunoreactive bands
was measured using Image-Pro Plus software and normal-
ized by house-keeping protein (GAPDH).
Quantitative real-time PCR
Total RNA was extracted using Trizol reagent (Invitro-
gen). 2 μg of total RNA was reversely transcripted using
MMLV Reverse Transcriptase (Invitrogen). Real-time PCR
was performed on a Rotor-Gene Q real-time PCR cycler
(Roche, Shanghai, China) using SYBR-green PCR master
mix kits. The data were analyzed using the Rotor-Gene Q
software (version 1.7, Qiagen), and relative mRNA levels
were calculated using the 2–△△Ct method and normalized
against 18S rRNA. The primers used for real-time PCR
were synthesized by Sangon Biotech (Shanghai, China).
Statistical analyses
Analysis of variance was conducted to examine whether
significant (P, 0.05) main treatment and time effects
occurred. Additional post hoc comparisons of treatment
means were conducted by using the Dunnett’s t-test
(treatments vs. controls) and Bonferroni t-test (selected
comparisons) as indicated. Data given represent mean-
sstandard deviation.
Results
FGF21 decreases the formation of foam cell fromTHP1
derived macrophages
With the development of atherosclerosis, the infiltrated
macrophages engulf LDL leading to the accumulation of
cholesterol in the droplets, and the formation of foam
cells. The uptake of ox-LDL by macrophages is the event
that triggers the formation of lipid-laden foam cells. The
oil red O-staining (Fig. 1a and b) and intracellular TC
quantitative assay (Fig. 1c) indicated that lipid content in
differentiated THP-1 cells was significantly increased by
ox-LDL, indicating the formation of foam cells. When
the cells were co-treated with FGF21, the lipid content
decreased dramatically as shown by the reduced lipid
droplets (Fig. 1a and b) and lower intracellular TC
(Fig. 1c). FACS analysis also demonstrated that ox-LDL
induced foam cells decreased dramatically after FGF21
treatment (Fig. 1d). These results show that FGF21 can
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decrease the accumulation of cholesterol and inhibit
foam cell formation in macrophages treated by ox-LDL.
FGF21 protects against ox-LDL and 7-KC induced
macrophage apoptosis
The apoptosis of foam cells duo to over-loaded choles-
terol is the key event during the development of athero-
sclerosis,. We wondered about the effect of FGF21 on
the apoptosis of macrophages induced by ox-LDL. As
demonstrated by FACS analysis results, the apoptosis of
THP1 derived macrophages increased significantly after
the treatment of ox-LDL (Fig. 2a and b). Consist with
the inhibitory effect of FGF21 on foam cell formation,
the apoptosis of THP1 derived macrophages induced by
the uptake of ox-LDL decreased dramatically when the
cells were treated by FGF21 (Fig. 2a and b). Ox-LDL is
composed of many potentially proatherogenic molecules.
7-ketocholesterol (7-KC), as one of the oxysterols, is
found in relatively large abundance in ox-LDL, as well as
in atherosclerotic plaque and foam cells in vivo. We won-
dered if FGF21 had the same effect on 7-KC induced
apoptosis of macrophages. As the results of FACS analysis,
FGF21 inhibited significantly the 7-KC induced apoptosis
of THP1 derived macrophages (Fig. 2c and d). These re-
sults revealed that FGF21 protected against ox-LDL and
oxysterols induced macrophage apoptosis.
The effect of FGF21 on macrophages is independent
upon ERK signaling pathway
ERK signaling pathway plays significant role in FGF21 func-
tion [20, 22]. To test if the inhibition function of FGF21 on
foam cell formation and apoptosis of macrophages is ERK
pathway dependent, siRNA selectively targeted ERK1/2
were used to knocked down the protein in macrophages.
Western blotting results showed that ERK1/2 protein
levels decreased dramatically after targeted siRNA trans-
fection in macrophages (Fig. 3a). As shown in Fig. 3b, in
compare with ox-LDL treatment group, FGF-21 alleviated
Fig. 1 FGF21 decreased foam cell formation of THP1 derived macrophages. a Representative images and (b) the average integrated optical
density (IOD) of lipid droplets stained with oil red O from differentiated macrophages treated by 50 mg/L ox-LDL in the presence or absence of
20 nmol/L FGF21 for 24 h. c The intracellular total cholesterol (TC) content was measured under the same conditions as in a. d Foam cells were
identified by FACS assay, representative images of FACS (left) and the percentages of apoptosis cells (right). Data are presented as the mean ± S.E.
of at least four independent experiments. *, p < 0.05, **, p < 0.01
Fig. 2 FGF21 protected against ox-LDL and 7-KC induced macrophage apoptosis. a THP1 derived macrophages apoptosis was test by Annexin V
and PI staining treated by ox-LDL in the presence or absence of FGF21 for 24 h. b Quantification of apoptosis cells in the FACS assay results of a.
c THP1 derived macrophages apoptosis was test by Annexin V and PI staining treated by 7-KC in the presence or absence of FGF21 for 24 h.
d Quantification of apoptosis cells in the FACS assay results of c. Data are presented as the mean ± S.E. of at least four independent experiments.
*, p < 0.05, **, p < 0.01
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cholesterol accumulation in both nc and si-ERK1/2
transfected cells, however, the less of ERK1/2 had no
significantly effect on lipid cholesterol accumulation
and foam cell formation in THP1 derived macrophages
(Fig. 3b and e). To further confirm that ERK1/2 signaling
pathway is not involved, we treated THP1 macrophage de-
rived foam cells with PD98059, a phosphorylated ERK1/2
specific inhibitor. With the addition of PD98059, ERK sig-
naling pathway was almost blocked as the decreased phos-
phorylated ERK1/2 levels (Fig. 3c). But the cholesterol
levels remained the same as that in the control group with
or without FGF21 treatment (Fig. 3d) These results demon-
strate that the functions of FGF21 on THP1 derived foam
cells are ERK signaling pathway independent.
FGF21 suppresses CHOP expression induced by ox-LDL
and 7-KC in macrophages
The apoptosis of macrophages induced by ox-LDL and
oxysterols is considered through the activated the
Unfolded Protein Response pathway (UPR pathway),
and CHOP, the important component in UPR pathway,
is considered as the key player. Interestingly, when we
tested the RNA and protein levels of CHOP in THP1
derived macrophages, we found that after FGF21 treatment,
ox-LDL induced RNA and protein levels of CHOP, were
deceased dramatically (Fig. 4a-c). The apoptosis of macro-
phages induced by 7-KC was also considered to be caused
by the upregulation of CHOP. In our data (Fig. 4b-c),
FGF21 also suppressed dramatically 7-KC induced CHOP
Fig. 3 The effect of FGF21 on macrophages is ERK signaling pathway independent. a The knockdown efficiency of ERK1/2 was tested by western
blotting in the THP1 derived macrophages transfected by siRNA. c Phosphorylated ERK1/2 level was tested in THP1 derived macrophages with or
without PD98059 treatment for 24 h. The intracellular total cholesterol (TC) content was measured in the THP1 derived macrophages treated by
ox-LDL in the presence or absence of FGF21 with ERK1/2 knockdown b or ERK1/2 specific inhibitor PD98059 d. Data are presented as the mean
± S. e. of at least four independent experiments. *, p < 0.05, **, p < 0.01. N.S, no significance
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expression. Additionally, Dearth Receptor 5 (DR5), the
direct downstream target of CHOP and the main mediator
in CHOP-mediated cell apoptosis, decreased significantly
after FGF21 treatment in THP1 derived macrophages
(Fig. 4c-d).
To investigate whether the reduction of CHOP is the
major reason of FGF21 protection effects, we introduced
siRNA specifically targeted CHOP to knockdown CHOP
in THP1 derived macrophages. After confirmation of
decreased CHOP levels as shown in Fig. 5a, the expres-
sion level of DR5 was downregulated in both oxLDL and
7-KC treated macrophages (Fig. 5b-c). With the inhib-
ition on CHOP signaling, the apoptosis of macrophages
induced by both oxLDL and 7-KC were dramatically
decreased after si-CHOP transfection (Fig. 5d-e). How-
ever, the protection of FGF21 on macrophage apoptosis
was almost abolished in macrophages when CHOP was
knockdown (Fig. 5d-e).
Fig. 4 FGF21 suppressed CHOP expression induced by ox-LDL and 7-KC in macrophages. CHOP mRNA level was tested by Real-time PCR in THP1
derived macrophages treated by ox-LDL (a) or 7-KC (b) in the presence or absence of FGF21 for 24 h, and 18S rRNA was used as internal control.
c CHOP protein level was tested by western blotting. d Quantification of the results in c. DR5 mRNA level was measured by Real-time PCR in
THP1 derived macrophages treated by ox-LDL (e) or 7-KC (f) in the presence or absence of FGF21. 18S rRNA was used as internal control. Data
are presented as the mean ± S.E. of at least three independent experiments. *, p < 0.05, **, p < 0.01. N.S, no significance
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So, the conclusion is that the protection effect of FGF21
on macrophage apoptosis is through CHOP pathway
suppression.
Discussion and conclusion
FGF21, as a member of hormone-like subgroup within the
FGF superfamily, is emerging as a key regulator of energy
homeostasis and a potential target for the treatment of
diabetes, cardiovascular disease, and obesity [4, 8, 23]. A
previous study showed that incubation of rodent car-
diac microvascular endothelial cells (CMECs) with oxi-
dized LDL led to increased FGF21 expression and
inhibited CMEC apoptosis [24]. These results sup-
ported the hypothesis that FGF21 function as an en-
dogenous protective factor in the cardiovascular system
can improve endothelial function during early stages of
atherosclerosis. Moreover, elevated serum FGF21 levels
have recently been reported in patients with CHD and
are associated with the presence of carotid artery
plaques [5, 8]. However, the role of FGF21 in athero-
sclerosis plaques remains unclear. In this study, we
present that FGF21 can protect macrophage against
foam cell formation and apoptosis.
In summary, FGF21 repressed the cholesterol accumu-
lation and foam cell formation in THP1 derived macro-
phage induced by ox-LDL or 7-KC. And the apoptosis of
foam cell was decreased with the treatment of FGF21.
Moreover,the effect of FGF21 on THP1 derived macro-
phages was ERK1/2 MAPK pathway independent,and
was mediated through suppressing the expression of
CHOP and its downstream target DR5. These findings
provide evidence for the role of FGF21 in arterioscler-
osis and present the new direction for atherosclerosis
prevention.
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